Explore more publications!

Press Releases

Kestra Medical Technologies Reports Preliminary Second Quarter Fiscal 2026 Financial Results
Artificio Introduces Data Series: Native Data Layer That Transforms Document Extraction into Business Intelligence
Committee Cliff Notes: Weekly Preview – Week of December 1, 2025
Kubernetes Backup Software Industry Analysis Report 2025: Key Trends, Drivers, and Forecast Insights
Sphera AI Supercharges Data to Address Sustainability and Operational Resilience Challenges
Carbon Steel Market Innovations & Growth | 2025 To 2032 Statistics Report
Cullinan Therapeutics Receives FDA Fast Track Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia
Akebia Announces Establishment of Rare Kidney Disease Pipeline
Beyond Oil Reports Financial Results for the Third Quarter of 2025
Doseology Announces Launch of Corporate Communications Program
Lead Nova Solutions Delivers 40% Efficiency Gains Through Strategic IT Consulting
Entrex (OTC: NTRX) to Present at NobleCon; Noble Capital Markets’ Annual Emerging Growth Conference
Altimmune Announces CEO Transition and Succession Plan
Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196, an Investigational Gene Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD)
Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196, an Investigational Gene Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD)
Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets
Master the Storm. Celebrate the Legend: Hongqi Golden Sunflower Guoya Honoured as SailGP Trophy Partner, Launches Middle East Pre-sales
Eos Energy Successfully Closes $600 Million Convertible Senior Notes Offering and Registered Direct Offering of Common Stock, Enhancing Financial Liquidity and Fueling U.S. Manufacturing Expansion
Bakersfield Man Pleads Guilty to Illegal Possession of Explosives and Manufacturing Methamphetamine

Bakersfield Man Pleads Guilty to Illegal Possession of Explosives and Manufacturing Methamphetamine

Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions